Navigation Links
Reportlinker Adds Global Syringes (Disposable and Reusable) Industry
Date:11/18/2010

nual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 74

Table 24: World 11-Year Perspective for Hypodermic Syringes by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia- Pacific (excluding Japan),

Middle East and Latin American Markets for Years 2005, 2010, &

2015 (includes corresponding Graph/Chart) 75

Table 25: World Recent Past, Current & Future Analysis for

Insulin Syringes by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Middle East and Latin

American Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 76

Table 26: World Historic Review for Insulin Syringes by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Middle East and Latin American Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 77

Table 27: World 11-Year Perspective for Insulin Syringes by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East and Latin American Markets for Years 2005, 2010, &

2015 (includes corresponding Graph/Chart) 78

Table 28: World Recent Past, Current & Future Analysis for

Intraligamentary Syringes by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Middle East and

Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 79

Table 29: World Historic Review for Intraligamentary Syringes

by Geographic Region - US, Canada, Japan,
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Reportlinker Adds US Prebiotics Industry
2. Reportlinker Adds Global Biosimilars (Follow-on biologics) Market: An Analysis
3. Reportlinker Adds TOP 10 DRUG DISCOVERY TECHNOLOGIES - STRATEGIC ANALYSIS AND GLOBAL FORECASTS
4. Reportlinker Adds Global HPLC Systems & Accessories Industry
5. Reportlinker Adds Global Blood Pressure Monitoring & Measurement Instruments Industry
6. Reportlinker Adds Global Freeze Drying Equipment Industry
7. Reportlinker Adds Global Surgical Incision Closures Industry
8. Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
9. Reportlinker Adds Global Uro-Gynecological Surgical Devices Industry
10. Reportlinker Adds Global Sterilization Systems & Equipment Industry
11. Reportlinker Adds Global Breast Pumps Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... a peer-reviewed publication of the results of the ... (RegeneRx,s preservative-free eye drops) for the treatment of ... environment (CAE ® ) model.  The exploratory study ... which were previously disseminated by the Company in ...
(Date:5/22/2015)... 22, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... systems ("EPS"), today announced that its CGuard TM Embolic ... investigator Prof. Piotr Musialek , at the EuroPCR ... France . PARADIGM, an investigator-initiated P ... A roti D revascularization I n symptomatic and ...
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
(Date:5/22/2015)... May 22, 2015 Omar Ahmad Barrada, ... to participate in the 2015 Congress of Future Medical ... as a gathering of “America’s highest achieving high school ... of healthcare, set new goals and learn better study ... live surgery, during which we can ask the surgeons ...
(Date:5/22/2015)... Family, friends, students, colleagues, mentors and ... Dr. LaSalle D. Leffall, on Monday, May 18, with ... Grand Rounds in the hospital’s Tower Auditorium. Leffall’s younger ... auditorium, trying to keep the secret. “I’d like to ... me, he’ll know something is up,” she said. , ...
(Date:5/22/2015)... 2015 According to a new Aegis Living ... equally as likely to worry about what will happen to ... 77% Boomers, 69% Silent Generation), which may help explain why ... of aging, particularly Millennials (47%), Gen X’ers (51%), and Boomers ... April, 2015 among more than 2,000 U.S. adults ages 18+. ...
(Date:5/22/2015)... According to Berks and Beyond , Pennsylvania has ... almost 2,500 confirmed drug deaths, as reported on May 7th. ... deaths stemming from legal and illegal drug use in 2014. ... day to fatal overdoses or other drug related deaths. The ... the most rife with drug related deaths. The city, along ...
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the opening of ... 16th sweetFrog store located in the Lone Star State. The ... Inc. 500 list of fastest growing companies in 2014. ... for 20 years and love the natural beauty and friendly ... Palestine, sweetFrog locations. “We are really excited about giving back ...
Breaking Medicine News(10 mins):Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2
... Administration (FDA) has accepted for filing the ... Neupro(R), (Rotigotine Transdermal System) as adjunctive therapy ... adult patients with advanced-stage Parkinson,s disease, ... New Drug Application (sNDA) for the use of Neupro(R) ...
... after drug-eluting stents is key, DALLAS, ... important after implanting a drug-eluting stent to ... joint Guidelines for Percutaneous,Coronary Intervention from the ... Society for Cardiovascular Angiography and,Interventions. The guidelines ...
... of us at Edward are proud,of CEO Pam Davis ... helping,federal authorities expose this corruption. Yet today,s indictment of ... more than four years,since Edward first filed an application ... hospital in Plainfield. The people of Plainfield,and surrounding areas ...
... Poll Shows Rural Seniors Want E-Prescribing in Medicare, ... so many issues, promoting electronic prescribing (e-prescribing) in,Medicare ... and Democrats can,agree on. "The Medicare Electronic Medication ... require that Medicare physicians begin to,prescribe electronically, will ...
... in on a DNA cluster that may encourage the ... carrying what,s known as a haplotype of a particular ... new study finds. , Haplotypes are clusters of genetic ... University of Kansas Medical Center (UKMC)collected blood samples and ...
... Decisions When Choosing,Nutritional Products, ANN ARBOR, ... steroid use in sports continue to emphasize ... nutrition products for banned,substances. NSF International,s Athletic ... athletes, coaches, trainers and anyone,concerned about banned ...
Cached Medicine News:Health News:Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease 2Health News:Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease 3Health News:Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease 4Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 2Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 3Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 4Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 5Health News:One Thing Washington Can Agree On: Time for E-Prescribing in Medicare 2Health News:One Thing Washington Can Agree On: Time for E-Prescribing in Medicare 3Health News:Genetics May Boost Mexican-Americans' Risk for Alcoholism 2Health News:Recent Reports Underscore the Importance of Testing Supplements for Athletic Banned Substances 2Health News:Recent Reports Underscore the Importance of Testing Supplements for Athletic Banned Substances 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: